PyöräläKDe BackerGGrahamI, et al.Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the ESC, EAS and ESH. Eur Heart J1994; 15: 1300–1331.
2.
BeuretHHauslerNNanchenD, et al.Comparison of Swiss and European risk algorithms for cardiovascular prevention in Switzerland. Eur J Prev Cardiol2020. Epub ahead of print, DOI: 10.1177/2047487320906305.
3.
ConroyRMPyöräläKFitzgeraldAP, et al.Estimation of ten-year risk of fatal cardiovascular disease in Europe: The SCORE project. Eur Heart J2003; 24: 987–1003.
4.
CooneyMTDudinaAD’AgostinoR, et al.Cardiovascular risk-estimation systems in primary prevention: Do they differ? Do they make a difference? Can we see the future?Circulation2010; 122: 300–310.
5.
De BacquerDDe BackerG. Predictive ability of the SCORE-Belgium risk chart for cardiovascular mortality. Int J Cardiol2010; 143: 385–390.
6.
KarjalainenTAdielsMBjörckL, et al.An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk. The Northern Sweden MONICA Study 1999–2014. Eur J Prev Cardiol2017; 24: 103–110.
7.
MachFBaigentCCatapanoA, et al.2019 ESC/EAS Guidelines fort he management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J2019; 41: 111–188.
8.
De BackerG. New risk markers for cardiovascular prevention. Curr Atheroscler Rep2014; 16: 427–427.
9.
PiepoliMHoesAWAgewallS, et al.2016 European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J2016; 37: 2315–2381.
10.
De BacquerDde SmedtDReinerZ, et al.Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study. Eur J Prev Cardiol. Epub ahead of print 9 September 2019. DOI: 10.1177/2047487319874898.
11.
Cordon A, de Meester C, Gerkens S, et al. Statins for the primary prevention of cardiovascular events. Health Technology Assessment (HTA). KCE Reports 306. Brussels: Belgian Health Care Knowledge Centre (KCE), 2019.
12.
SalamiJAWarraichHValero-ElizondoJ, et al.National trends in statin use and expenditure in the US adult population from 2002 to 2013. JAMA Cardiol2017; 2: 56–65.
13.
RoseG. The strategy of preventive medicine, Oxford, New York, Tokyo: Oxford University Press, 1992.
